Energetic dissection of Gleevec's selectivity toward human tyrosine kinases

Area of Science:

• Biochemistry
• Molecular Biology
• Pharmacology

Background:

• Protein kinases play crucial roles in cellular regulation and are primary targets for cancer drug development.
• Gleevec, a successful Abl kinase inhibitor, highlights the need to understand kinase specificity.
• Previous research has struggled to explain differential binding affinities between similar kinases like Abl and Src.

Purpose of the Study:

• To elucidate the molecular mechanism behind the vastly different affinities of Abl and Src tyrosine kinases for Gleevec.
• To propose a new model explaining kinase-inhibitor interactions and specificity.

Main Methods:

• Nuclear Magnetic Resonance (NMR) spectroscopy
• Fast kinetics assays
• Computational modeling of energy landscapes

Main Results:

• Abl and Src kinases adopt nearly identical structures when bound to Gleevec.
• Abl kinase's high affinity for Gleevec is primarily due to a post-binding conformational change, not pre-existing structural differences.
• The study introduces a novel energy landscape model to explain these binding dynamics.

Conclusions:

• The findings challenge existing models of kinase-inhibitor interactions.
• A conformational selection mechanism coupled with induced fit explains differential binding affinities.
• This energy landscape model may be applicable to a wide range of kinase inhibitors in cancer therapy.